Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’ – a molecule derived from glucose – acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.
The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases – and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.
Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.
Professor O’Neill said: “My lab has been exploring metabolic changes in macrophages for the past six years and we’ve come across what we think is the most important finding yet.”
“It is well known that macrophages cause inflammation, but we have just found that they can be coaxed to make a biochemical called itaconate. This functions as an important brake, or off-switch, on the macrophage, cooling the heat of inflammation in a process never before described.”
Dr Evanna Mills, who, with Dylan Ryan was joint first author of the work, said: “The macrophage takes the nutrient glucose, whose day job it is to provide energy, and surprisingly turns it into itaconate. This then blocks production of inflammatory factors, and also protects mice from the lethal inflammation that can occur during infection.”
Dylan Ryan added: “We’ve found that itaconate can directly modify a whole host of proteins important for inflammation in a chemical reaction never before described, and that this reaction is important for the anti-inflammatory effects of itaconate.”
The discovery is very much on the frontier of inflammation research and Professor O’Neill and his collaborators are now exploring its relevance to the onset and development of inflammatory and infectious diseases. They are also keen to explore whether the findings can be exploited in the effort to develop new anti-inflammatory medicines.
The work was a collaboration with Harvard Medical School, the University of Cambridge, the University of Oxford, Johns Hopkins University, the University of Dundee, and GlaxoSmithKline, where both Professor O’Neill and Dr Mills spent time on sabbatical.
Professor O’Neill said: “This discovery and the new research pathways it has opened up will keep us busy for some time but we are hopeful that it will one day make a difference to patients with diseases that remain difficult to treat.”
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
How to Reduce Inflammation
on July 11, 2018 at 12:25 pm
Consumer Reports has no financial relationship with advertisers on this site. T he term “inflammation” gets thrown around a lot these days. But what does it really mean, and how does it affect your he... […]
A study points to new therapeutic targets for tumors associated with chronic inflammation
on July 11, 2018 at 10:46 am
Scientists report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. Scientists headed by ICREA researcher Angel R. Nebr... […]
Proper Burial of Dead Cells Limits Inflammation
on July 11, 2018 at 10:21 am
Dead cells that accumulate in the body can contribute to inflammation and predispose people to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn’s d... […]
Scientists pinpoint new therapeutic targets for inflammation-associated colon cancer
on July 11, 2018 at 7:57 am
Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associate... […]
New therapeutic targets for tumours associated with chronic inflammation
on July 11, 2018 at 6:21 am
Bowel of a patient with Ulcerative Colitis, a chronic inflammatory bowel disease. In green: macrophage marker, in red: activated p38 protein, in blue: nucleus. Credit: Catrin Youssif, IRB Barcelona. S... […]
Seal serum offers protection from inflammation
on July 10, 2018 at 5:32 am
Weddell seals diving under the ice. Researchers hope to apply their findings regarding the protection provided by seal serum to extend the survival of organs used in transplant surgery. Credit: change... […]
Novel PET imaging method more fully evaluates extent of rheumatoid arthritis inflammation
on July 9, 2018 at 6:11 am
CT and 11C-PBR28 PET SUV images of both knees of (i) an RA patient with clinical signs of synovitis both knees, and (ii) a healthy control. Credit: N Narayan et al. 2018, University of Oxford, Heading... […]
Ultra-thin sensor makes inflammation testing and curing 30 times faster
on July 6, 2018 at 12:18 pm
Researchers have developed a real-time ultraflexible sensor that makes inflammation testing and curing 30 times faster. Different from the inorganic counterparts like silicon, organic semiconductors c... […]
Team develops an ultra-thin sensor that makes inflammation testing and curing 30 times faster
on July 6, 2018 at 6:42 am
Members of the research team (from left): Mr. Ji Xudong, Dr. Paddy Chan Kwok-leung and Professor Gilberto Leung Ka-kit. Credit: @The University of Hong Kong Different from the inorganic counterparts l... […]
via Bing News